Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model

Abstract Background The Glass model developed in 2003 uses prognostic factors for noncastrate metastatic prostate cancer (NCMPC) to define subgroups with good, intermediate, and poor prognosis. Objective To validate NCMPC risk groups in a more recently diagnosed population and to develop a more sens...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European urology 2015-08, Vol.68 (2), p.196-204
Hauptverfasser:	Gravis, Gwenaelle, Boher, Jean-Marie, Fizazi, Karim, Joly, Florence, Priou, Franck, Marino, Patricia, Latorzeff, Igor, Delva, Remy, Krakowski, Ivan, Laguerre, Brigitte, Walz, Jochen, Rolland, Fréderic, Théodore, Christine, Deplanque, Gael, Ferrero, Jean-Marc, Pouessel, Damien, Mourey, Loïc, Beuzeboc, Philippe, Zanetta, Sylvie, Habibian, Muriel, Berdah, Jean-François, Dauba, Jerome, Baciuchka, Marjorie, Platini, Christian, Linassier, Claude, Labourey, Jean-Luc, Machiels, Jean Pascal, El Kouri, Claude, Ravaud, Alain, Suc, Etienne, Eymard, Jean-Christophe, Hasbini, Ali, Bousquet, Guilhem, Soulie, Michel, Oudard, Stéphane
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - blood Adenocarcinoma - drug therapy Adenocarcinoma - mortality Adenocarcinoma - secondary Aged Alkaline phosphatase Alkaline Phosphatase - blood Androgen Antagonists - therapeutic use Antineoplastic Agents, Hormonal - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biomarkers, Tumor - blood Bone Neoplasms - mortality Bone Neoplasms - secondary Decision Support Techniques Docetaxel France Humans Kaplan-Meier Estimate Life Sciences Lymphatic Metastasis Male Metastatic Middle Aged Nomograms Noncastrate Orchiectomy Predictive Value of Tests Prognostic factors Proportional Hazards Models Prospective Studies Prostate cancer Prostatic Neoplasms - blood Prostatic Neoplasms - drug therapy Prostatic Neoplasms - mortality Prostatic Neoplasms - pathology Reproducibility of Results Risk Assessment Risk Factors Taxoids - therapeutic use Time Factors Treatment Outcome Urology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!